Αρχειοθήκη ιστολογίου

Παρασκευή 24 Αυγούστου 2018

Defective TLR9-driven STAT3 activation in B cells of patients with CVID

Publication date: Available online 23 August 2018

Source: Clinical Immunology

Author(s): Arturo Borzutzky, Ingrid Rauter, Ari Fried, Rima Rachid, Douglas R. McDonald, Lennart Hammarstrom, Bodo Grimbacher, Roshini S. Abraham, Raif S. Geha

Abstract

B cell activation by Toll-like receptor 9 (TLR9) ligands is dependent on STAT3 and is important for optimal antibody responses to microbial antigens. B cells from patients with common variable immune deficiency (CVID) have impaired proliferation and differentiation in response to the TLR9 ligand CpG, despite normal levels of TLR9 expression. We demonstrate that CpG-driven STAT3 phosphorylation, but not activation of NFκB and p38, is selectively impaired in B cells from CVID patients. These results suggest that defective STAT3 activation contributes to the defective TLR9 and antibody response of B cells in CVID.



https://ift.tt/2BIdDjn

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου